Rye, Kerry-Anne - University of New South Wales

个人简介

Kerry-Anne Rye obtained her PhD from The Flinders University of South Australia in 1986 and gained her postdoctoral training at The University of Illinois at Urbana Champaign. She is a Research Professor and director of the Lipid Research Group, University of New South Wales. She is an Associate Editor of the Journal of Lipid Research, and an Editorial Board Member of three American Heart Associaiton journals: Arteriosclerosis, Thrombosis and Vascular Biology; The Journal of the American Heart Association and Circulation Research. Professor Rye is the Immediate-past Chair of the American Heart Association ATVB Council Women’s Leadership Committee, a member of the ATVB Leadership and International Mentoring Committees, Chair of the Program Committee (ATVB Council nominee) for American Heart Association Scientific Sessions and runs a mentoring program for early career members of the ATVB Council.

研究领域

Cardiovascular Medicine and Haematology not elsewhere classified

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Anastasius M; Kockx M; Jessup W; Sullivan D; Rye KA; Kritharides L, 2016, 'Cholesterol efflux capacity: An introduction for clinicians', American Heart Journal, vol. 180, pp. 1 - 10, http://dx.doi.org/10.1016/j.ahj.2016.07.005 Kritharides L; Rye KA; Lambert TJ; Jessup W, 2016, 'Lipidology, cardiovascular risk, and schizophrenia', Current Opinion in Lipidology, vol. 27, no. 3, pp. 305 - 307, http://dx.doi.org/10.1097/MOL.0000000000000307 Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA, 2016, 'In vivo PET imaging with [18F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes', Diabetologia, vol. 59, no. 9, pp. 1977 - 1984, http://dx.doi.org/10.1007/s00125-016-3993-5 Geronimo FRB; Barter PJ; Rye KA; Heather AK; Shearston KD; Rodgers KJ, 2016, 'Plaque stabilizing effects of apolipoprotein A-IV', Atherosclerosis, vol. 251, pp. 39 - 46, http://dx.doi.org/10.1016/j.atherosclerosis.2016.04.019 Sultana A; Cochran BJ; Tabet F; Patel M; Torres LC; Barter PJ; Rye KA, 2016, 'Inhibition of inflammatory signaling pathways in 3T3-L1 adipocytes by apolipoprotein A-I', The FASEB Journal, vol. 30, no. 6, pp. 2324 - 2335, http://dx.doi.org/10.1096/fj.201500026R Kockx M; Glaros E; Leung B; Ng TW; Berbée JFP; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PCN; Meikle PJ; Kritharides L, 2016, 'Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia', Arteriosclerosis, Thrombosis and Vascular Biology, vol. 36, no. 7, pp. 1338 - 1349, http://dx.doi.org/10.1161/ATVBAHA.115.307030 Siebel AL; Trinh SK; Formosa MF; Mundra PA; Natoli AK; Reddy-Luthmoodoo M; Huynh K; Khan AA; Carey AL; Van Hall G; Cobelli C; Dalla-Man C; Otvos JD; Rye KA; Johansson J; Gordon A; Wong NCW; Sviridov D; Barter P; Duffy SJ; Meikle PJ; Kingwell BA, 2016, 'Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial', Metabolism: clinical and experimental, vol. 65, no. 6, pp. 904 - 914, http://dx.doi.org/10.1016/j.metabol.2016.03.002 Tabet F; Torres LFC; Ong KL; Shrestha S; Choteau SA; Barter PJ; Clifton P; Rye KA, 2016, 'High-density lipoprotein-associated miR-223 is altered after diet-induced weight loss in overweight and obese males', PLoS One, vol. 11, no. 3, http://dx.doi.org/10.1371/journal.pone.0151061 Barter PJ; Rye KA, 2016, 'Coronary artery disease: Scavenger receptor class B1-a target to reduce CHD risk?', Nature Reviews Cardiology, vol. 13, no. 5, pp. 249 - 250, http://dx.doi.org/10.1038/nrcardio.2016.50 Julovi SM; Xue A; Thanh Le TN; Gill AJ; Bulanadi JC; Patel M; Waddington LJ; Rye KA; Moghaddam MJ; Smith RC, 2016, 'Apolipoprotein A-II plus lipid emulsion enhance cell growth via SR-B1 and target pancreatic cancer in vitro and in vivo', PLoS One, vol. 11, no. 3, http://dx.doi.org/10.1371/journal.pone.0151475 Barter PJ; Rye KA, 2016, 'New era of lipid-lowering drugs', Pharmacological Reviews, vol. 68, no. 2, pp. 458 - 475, http://dx.doi.org/10.1124/pr.115.012203 Barter PJ; Rye KA, 2016, 'Cholesteryl ester transfer protein inhibition is not yet dead - Pro', Arteriosclerosis, Thrombosis and Vascular Biology, vol. 36, no. 3, pp. 439 - 441, http://dx.doi.org/10.1161/ATVBAHA.115.306879 Barter PJ; Rye KA, 2016, 'Cholesteryl Ester Transfer Protein Inhibition Is Not Yet Dead—Pro', Arteriosclerosis, Thrombosis and Vascular Biology, http://dx.doi.org/10.1161/ATVBAHA.115.306879 Puranik R; Bao S; Bonin AM; Kaur R; Weder JE; Casbolt L; Hambley TW; Lay PA; Barter PJ; Rye KA, 2016, 'A novel class of copper(II)- and zinc(II)-bound non-steroidal anti-inflammatory drugs that inhibits acute inflammation in vivo', Cell and Bioscience, vol. 6, no. 1, http://dx.doi.org/10.1186/s13578-016-0076-8 Rye KA; Barter PJ; Cochran BJ, 2016, 'Apolipoprotein A-I interactions with insulin secretion and production', Current Opinion in Lipidology, vol. 27, no. 1, pp. 8 - 13, http://dx.doi.org/10.1097/MOL.0000000000000253 Barter PJ; Rye KA, 2015, 'Targeting High-density Lipoproteins to Reduce Cardiovascular Risk: What Is the Evidence?', Clinical Therapeutics: the international peer-reviewed journal of drug therapy, vol. 37, no. 12, pp. 2716 - 2731, http://dx.doi.org/10.1016/j.clinthera.2015.07.021 Rye KA; Barter PJ; Brown AJ, 2015, 'Speed kills in more ways than one: Methamphetamine and atherosclerosis', Atherosclerosis, vol. 243, no. 2, pp. 654 - 655, http://dx.doi.org/10.1016/j.atherosclerosis.2015.09.034 Barter PJ; Tabet F; Rye KA, 2015, 'Reduction in PCSK9 levels induced by anacetrapib: An off-target effect?', Journal of Lipid Research, vol. 56, no. 11, pp. 2085 - 2093, http://dx.doi.org/10.1194/jlr.C063768 Bisoendial R; Tabet F; Tak PP; Petrides F; Cuesta Torres LF; Hou L; Cook A; Barter P; Weninger W; Rye KA, 2015, 'Apolipoprotein A-I Limits the Negative Effect of Tumor Necrosis Factor on Lymphangiogenesis', Arteriosclerosis, Thrombosis and Vascular Biology, http://dx.doi.org/10.1161/ATVBAHA.115.305777 Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA, 2015, 'Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis', International Journal of Cardiology, vol. 199, pp. 204 - 212, http://dx.doi.org/10.1016/j.ijcard.2015.07.014